Oncolytics Biotech Inc ONCY

New hiring position

[jh1970]

Senior Medical Writer

Reporting To:

Chief Medical Officer

Location:

Calgary, Alberta or San Diego, California (Office-Based)

Summary:

This position supports Oncolytics’ Clinical Development, Clinical Operations and Regulatory Affairs teams in writing and coordinating the writing and review of technical documents for the Company

Key Responsibilities:

The Senior Medical Writer is responsible for the development and management of medical writing deliverables in support of key Oncolytics functions including Clinical Development, Clinical Operations, and Regulatory Affairs.

The specific responsibilities of this role include, but are not limited to:

• Serve as the primary writer for a range of medical writing projects including the design, planning, and preparation of documents supporting clinical development (e.g., study protocols, study reports, investigator brochures, etc.), regulatory activities (e.g., briefing materials, clinical modules, etc.), and manuscript preparation.
• Ensure that documents are high-quality in terms of scientific content, organization, clarity, accuracy, format, consistency, and adherence to relevant internal and external (e.g., regulatory) guidelines.
• Review, edit, and ensure the quality of documents prepared by other medical writers (internal or external) and functional area representatives.
• Ensure that medical writing activities are coordinated with other departments, including Regulatory Affairs, Clinical Development, Pharmacovigilance, etc., and that timelines are met.
• Ensure consistent messaging across documents (nonclinical, clinical, regulatory, etc.).
• Oversee and coordinate the activities of contract writers engaged by Oncolytics.
• Work collaboratively with colleagues in other departments (e.g., Clinical Development, Clinical Operations, Regulatory Affairs, Statistics/Data Management, Pharmacovigilance, etc.).
• Help maintain the Trial Master File and ensure it is current.
• Train and mentor junior writers and work closely with other members of the Oncolytics’ Medical Writing team.
• Other tasks as required

Qualifications:

• Excellent written and oral communication skills.
• Well-developed organizational skills, thorough with excellent attention to detail.
• Strong analytical and problem-solving ability, innovative and creative, good judgment; ability to identify risks to timelines and data
• Self-motivated with the ability to work both independently and collaboratively as a member of a team; good leadership
• Knowledge and understanding of FDA and ICH guidelines, Good Clinical Practices (GCP), medical terminology, clinical trial methodology, and drug development processes.
• Oncology drug development experience desirable but not required.
• Able to travel domestically and internationally approximately 2-3 times a year if required.

Education & Experience:

• A bachelor’s degree, preferably in a scientific or technical discipline, is required.
• A minimum of 3-5 years of previous professional medical writing experience in a pharmaceutical, biotechnology or medical-related

To apply, please provide a resume and cover letter to [e-mail] 

[CMHarring218431]

Do you know when this notice appeared on the site? When the "affirm" and "confirm" debate was happening, someone posted that Onc had a  top notch and well respected medical writer. Now, apparently we have a second departure/firing. Wonder if the two are connected and why.

[pelaboost]

@CMH. It was me that said we had a good writer; I was referring to the current CMO. It appears that the new writer will report to the CMO. I would assume we are adding an employee, and presuming our current CMO will be attending to weightier matters than writing. This all costs money; let us hope there is something in the Xmas stocking.

[Noteable]

ONCY’s CMO will be quite busy with ONCY’s potential request for an Accelerated Approval, the filing of a Phase 3 confirmatory trial in mPDAC with the FDA, and the management / transition of medical / scientific information to a Big Pharma partner / acquirer.

[Noteable]

This new job opening unmistakenly indicates that ONCY is scaling up its corporate structure to manage contract services organizations (CROs) in advance of ONCY’s putative filing of a Phase 3 confirmatory clinical trial in mPDAC.